Citius Oncology, Inc. Common Stock

Go to Citius Oncology, Inc. Common Stock Website

$2.09

0.03 (1.46%)
Live
Previous Close

$2.06

Day Range

$2.05 - $2.12

Previous Day Range

$2.06 - $2.31

Market Cap

$161.4 million USD

Day Vol.

144686

Previous Day Vol.

614668

Currency

USD

Primary Exchange

None

Citius Oncology Inc is a specialty pharmaceutical company dedicated to the development and commercialization of critical care products targeting unmet needs with a focus on oncology products. In addition, Citius completed enrollment in its Phase 2b t...


Community
  • 0 posts discussing
0

Watchers

0

Visitors


Recent News

Citius Oncology priced a public offering of 6,818,182 shares and warrants at $1.32 per share, expecting to raise approximately $9.0 million to support LYMPHIR commercialization and general corporate purposes.

Related tickers: CTOR, CTXR.

Read Full Article

Cancer research companies are attracting investor interest as the oncology market is projected to grow significantly, with several firms showing promising clinical trial results and strategic developments in cancer treatments.

Related tickers: CELC, CTOR, EXEL.

Read Full Article
Trending Tickers

Please sign in to view